Methylergonovine maleate - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for methylergonovine maleate and what is the scope of freedom to operate?
Methylergonovine maleate
is the generic ingredient in two branded drugs marketed by Edison Theraps Llc, Am Regent, Breckenridge, Amneal Pharms, Chartwell Rx, Granules, Rising, Teva Pharms Usa, and Trupharma, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.There is one drug master file entry for methylergonovine maleate. Thirteen suppliers are listed for this compound.
Summary for methylergonovine maleate
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 9 |
NDAs: | 9 |
Drug Master File Entries: | 1 |
Finished Product Suppliers / Packagers: | 13 |
Raw Ingredient (Bulk) Api Vendors: | 42 |
Clinical Trials: | 4 |
Patent Applications: | 553 |
Drug Prices: | Drug price trends for methylergonovine maleate |
What excipients (inactive ingredients) are in methylergonovine maleate? | methylergonovine maleate excipients list |
DailyMed Link: | methylergonovine maleate at DailyMed |
Recent Clinical Trials for methylergonovine maleate
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Johns Hopkins University | Early Phase 1 |
Brigham and Women's Hospital | Phase 4 |
University of California, San Francisco | Phase 4 |
Pharmacology for methylergonovine maleate
Drug Class | Ergot Derivative |
Medical Subject Heading (MeSH) Categories for methylergonovine maleate
US Patents and Regulatory Information for methylergonovine maleate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Edison Theraps Llc | METHERGINE | methylergonovine maleate | TABLET;ORAL | 006035-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Teva Pharms Usa | METHYLERGONOVINE MALEATE | methylergonovine maleate | TABLET;ORAL | 211455-001 | Mar 20, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Chartwell Rx | METHYLERGONOVINE MALEATE | methylergonovine maleate | TABLET;ORAL | 091577-001 | May 2, 2011 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Am Regent | METHYLERGONOVINE MALEATE | methylergonovine maleate | INJECTABLE;INJECTION | 090193-001 | Nov 24, 2008 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.